2 news items
Pulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (nsPFAâ„¢) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting
PLSE
16 May 24
clinical successes and whether they are predictive of the safety and efficacy of any medical device, and the Company's expectations, whether stated
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
PLSE
9 May 24
them the potential to set new standards for safety and efficacy as well as decreased workflow time from patient set-up to procedure finish
- Prev
- 1
- Next